PI3K/AKT/mTOR protein pathway signaling in patients with lymph node metastasis (n = 6), did not reveal common, complete pathway up or down modulation for all 6 patients (Fig. 3C and Supplemental Fig. 9). This evidence concerns the gene MTOR and metastatic malignant neoplasm in the lymph nodes.